TILADE

This brand name is authorized in Australia, Austria.

Active ingredients

The drug TILADE contains one active pharmaceutical ingredient (API):

1	Nedocromil UNII ET8IF4KS1T - NEDOCROMIL SODIUM
	Nedocromil is a non-steroidal agent, which has anti-inflammatory properties when administered topically in the lung. In the treatment of bronchial asthma, nedocromil sodium reduces bronchospasm, cough and bronchial hyperreactivity and improves objective measurements of lung function.
	Read more about Nedocromil

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
TILADE Pressurised inhalation suspension	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
R03BC03	Nedocromil	R Respiratory system → R03 Drugs for obstructive airway diseases → R03B Other drugs for obstructive airway diseases, inhalants → R03BC Antiallergic agents, excl. corticosteroids
Discover more medicines within R03BC03
S01GX04	Nedocromil	S Sensory organs → S01 Ophthalmologicals → S01G Decongestants and antiallergics → S01GX Other antiallergics
Discover more medicines within S01GX04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	8365G